Skip to content Skip to navigation

Extracochlear neurostimulation - auricle

Hair bundle of Guinea pig cochlea.
CC0 1.0

Sensorineural hearing loss is an increasingly prevalent condition that causes disability to over a third of US adults aged over 65. As the condition progresses, it selectively affects high-frequency hearing that is critical for speech comprehension. For the 1.2M US adults with bilateral severe-to-profound high-frequency loss the only available treatment is a cochlear implant, however the risk of residual hearing loss associated with this irreversible procedure leads most patients to forgo treatment. We are developing a breakthrough device to restore high-frequency hearing that preserves residual hearing through a reversible and minimally invasive approach.

Participants

 

Team Members: 
Jay Dhuldhoya MS (BME), Biodesign Fellow
Francis Wong, MBBS, MBA, MPH, Biodesign Fellow
Jaime Lopez, MD, Professor of Neurology and Director of Intraoperative Neuromonitoring
Matt Fitzgerald, PhD, Chief of Audiology
Nikolas Blevins, MD, Professor of Otolaryngology, Chief of Neurotology

 
Funding Type: 
Neuroscience:Translate
Round: 
3
Award Year: 
2021